Last reviewed · How we verify

Enoksetin — Competitive Intelligence Brief

Enoksetin (ENOXACIN) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: enoxacin. Area: Infectious Disease.

marketed enoxacin RISC-loading complex subunit TARBP2 Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Enoksetin (ENOXACIN).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Enoksetin TARGET ENOXACIN marketed enoxacin RISC-loading complex subunit TARBP2 1991-01-01
ENOXA® ENOXA® Les Laboratoires des Médicaments Stériles marketed RISC-loading complex subunit TARBP2, V-type proton ATPase subunit B, brain isoform, DNA gyrase
Geninax GARENOXACIN marketed garenoxacin 2007-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (enoxacin class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Enoksetin — Competitive Intelligence Brief. https://druglandscape.com/ci/enoxacin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: